Synapsin Pharmaceuticals, Inc. — Form D
Synapsin Pharmaceuticals, Inc. of COLUMBIA, SC, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-20. The offering totals $3.8M, of which $375K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-07-20
- Form: D
- Accession: 0001679593-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.8M
- Amount sold: $375K
- Remaining: $3.4M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2016-07-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-267417
Issuer
- Name: Synapsin Pharmaceuticals, Inc.
- CIK: 0001679593
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1225 LAUREL STREET, COLUMBIA, SC, 29201
- Phone: 8035450075
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| John Dorsey Denis | Director | COLUMBIA, SC |
| MARK Dorsey KINDY | Director | TAMPA, FL |
| John Dorsey Denis | Executive Officer | COLUMBIA, SC |
| MARK Dorsey KINDY | Executive Officer | TAMPA, FL |
More